Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 232

1.

Characterization of two polymorphs of lornoxicam.

Zhang J, Tan X, Gao J, Fan W, Gao Y, Qian S.

J Pharm Pharmacol. 2013 Jan;65(1):44-52. doi: 10.1111/j.2042-7158.2012.01573.x. Epub 2012 Aug 5.

PMID:
23215687
2.

Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.

Maghsoodi M, Sadeghpoor F.

Drug Dev Ind Pharm. 2010 Aug;36(8):917-25. doi: 10.3109/03639040903585127.

PMID:
20180658
3.

Crystal forms of piroxicam pivalate: preparation and characterization of two polymorphs.

Giordano F, Gazzaniga A, Moyano JR, Ventura P, Zanol M, Peveri T, Carima L.

J Pharm Sci. 1998 Mar;87(3):333-7.

PMID:
9523987
4.

Solid state manipulation of lornoxicam for cocrystals--physicochemical characterization.

Nijhawan M, Santhosh A, Babu PR, Subrahmanyam CV.

Drug Dev Ind Pharm. 2014 Sep;40(9):1163-72. doi: 10.3109/03639045.2013.804834. Epub 2013 Jul 5.

PMID:
23829186
6.

Structural characterization of two polymorphic forms of piroxicam pivalate.

Caira MR, Zanol M, Peveri T, Gazzaniga A, Giordano F.

J Pharm Sci. 1998 Dec;87(12):1608-14.

PMID:
10189275
7.

Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate.

Ambrogi V, Perioli L, Marmottini F, Giovagnoli S, Esposito M, Rossi C.

Eur J Pharm Sci. 2007 Nov;32(3):216-22. Epub 2007 Aug 6.

PMID:
17826966
8.

Thermal, spectroscopic, and ab initio structural characterization of carprofen polymorphs.

Bruni G, Gozzo F, Capsoni D, Bini M, Macchi P, Simoncic P, Berbenni V, Milanese C, Girella A, Ferrari S, Marini A.

J Pharm Sci. 2011 Jun;100(6):2321-32. doi: 10.1002/jps.22470. Epub 2011 Jan 18.

PMID:
21246561
9.

Innovation of novel sustained release compression-coated tablets for lornoxicam: formulation and in vitro investigations.

Hamza Yel-S, Aburahma MH.

Drug Dev Ind Pharm. 2010 Mar;36(3):337-49. doi: 10.1080/03639040903170768.

PMID:
19722915
10.

Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.

Lai F, Pini E, Corrias F, Perricci J, Manconi M, Fadda AM, Sinico C.

Int J Pharm. 2014 Jun 5;467(1-2):27-33. doi: 10.1016/j.ijpharm.2014.03.047. Epub 2014 Mar 26.

PMID:
24680963
11.

Crystal forms of naproxen.

Song JS, Sohn YT.

Arch Pharm Res. 2011 Jan;34(1):87-90. doi: 10.1007/s12272-011-0110-7. Epub 2011 Apr 6.

PMID:
21468919
12.

Characterization of nicergoline polymorphs crystallized in several organic solvents.

Malaj L, Censi R, Capsoni D, Pellegrino L, Bini M, Ferrari S, Gobetto R, Massarotti V, Di Martino P.

J Pharm Sci. 2011 Jul;100(7):2610-22. doi: 10.1002/jps.22477. Epub 2011 Jan 19.

PMID:
21254066
13.

Piroxicam/2-hydroxypropyl-beta-cyclodextrin inclusion complex prepared by a new fluid-bed coating technique.

Zhang X, Wu D, Lai J, Lu Y, Yin Z, Wu W.

J Pharm Sci. 2009 Feb;98(2):665-75. doi: 10.1002/jps.21453.

PMID:
18543294
14.

Solid-state characterization of mefenamic acid.

Panchagnula R, Sundaramurthy P, Pillai O, Agrawal S, Raj YA.

J Pharm Sci. 2004 Apr;93(4):1019-29.

PMID:
14999737
15.

Melt sonocrystallized piroxicam for oral delivery: particle characterization, solid state analysis, and pharmacokinetics.

Gupta PS, Sharma V, Pathak K.

Expert Opin Drug Deliv. 2013 Jan;10(1):17-32. doi: 10.1517/17425247.2013.736961. Epub 2012 Oct 29.

PMID:
23102052
16.

Preparation, structural analysis, and properties of tenoxicam cocrystals.

Patel JR, Carlton RA, Needham TE, Chichester CO, Vogt FG.

Int J Pharm. 2012 Oct 15;436(1-2):685-706. doi: 10.1016/j.ijpharm.2012.07.034. Epub 2012 Jul 25.

PMID:
22841852
17.

Influence of solvent evaporation rate and formulation factors on solid dispersion physical stability.

Wu JX, Yang M, Berg Fv, Pajander J, Rades T, Rantanen J.

Eur J Pharm Sci. 2011 Dec 18;44(5):610-20. doi: 10.1016/j.ejps.2011.10.008. Epub 2011 Oct 17.

PMID:
22024381
18.

Solid-state characterization of chlordiazepoxide polymorphs.

Singh D, Marshall PV, Shields L, York P.

J Pharm Sci. 1998 May;87(5):655-62.

PMID:
9572919
19.

Preparation and characterization of a novel polymorph of indiplon, Form α.

Xu L, Wang J, Xiao B, Yang J, Liu Y, Huang R.

Bioorg Med Chem Lett. 2012 Jan 15;22(2):963-8. doi: 10.1016/j.bmcl.2011.12.013. Epub 2011 Dec 9.

PMID:
22209207
20.

Characterization of polymorphic ampicillin forms.

Baraldi C, Tinti A, Ottani S, Gamberini MC.

J Pharm Biomed Anal. 2014 Nov;100:329-40. doi: 10.1016/j.jpba.2014.08.021. Epub 2014 Aug 26.

PMID:
25194347
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk